enGene Holdings Inc. Contracts & Agreements
42 Contracts & Agreements
- Business Finance (8 contracts)
- Business Operations (2)
- Human Resources (22)
- Real Estate (5)
- Uncategorized (5)
- Open Market Sale AgreementSM, dated December 20, 2024, by and between enGene Holdings Inc. and Jefferies LLC (Filed With SEC on December 20, 2024)
- First Amendment to Amended and Restated Loan and Security Agreement, dated December 18, 2024 (Filed With SEC on December 19, 2024)
- Separation and General Release Agreement, dated October 16, 2024, by and between enGene USA, Inc. and James Sullivan (Filed With SEC on December 19, 2024)
- Employment Agreement, dated October 21, 2024, by and between enGene USA, Inc. and Joan Connolly (Filed With SEC on December 19, 2024)
- Amended and Restated Employment Agreement, dated October 21, 2024, by and between enGene Inc. and Anthony T. Cheung (Filed With SEC on December 19, 2024)
- Form of Subscription Agreement, dated October 24, 2024 (Filed With SEC on October 25, 2024)
- Amended and Restated Employment Agreement, dated October 16, 2024, by and between enGene USA, Inc. and Alexander Nichols (Filed With SEC on October 21, 2024)
- Employment Agreement, dated July 22, 2024, by and between enGene USA, Inc. and Raj Pruthi (Filed With SEC on September 10, 2024)
- Transition Services Agreement and General Release, dated July 16, 2024, by and between enGene USA, Inc. and Richard Bryce (Filed With SEC on September 10, 2024)
- Inducement Grant Agreement, dated July 22, 2024, by and between enGene Holdings Inc. and Ronald H. W. Cooper (Filed With SEC on September 10, 2024)
- Amendment to Transition and Modification Agreement, dated July 23, 2024, by and between enGene USA, Inc. and Jason D. Hanson (Filed With SEC on July 24, 2024)
- Employment Agreement, dated July 22, 2024, by and between enGene USA, Inc. and Ronald H. W. Cooper (Filed With SEC on July 24, 2024)
- Employment Agreement, dated April 22, 2024, by and between enGene USA, Inc. and Lee Giguere (Filed With SEC on June 14, 2024)
- Amended and Restated enGene Holdings Inc. 2023 Incentive Equity Plan (Filed With SEC on May 15, 2024)
- Transition and Modification Agreement, dated February 13, 2024 by and between enGene USA, Inc. and Jason D. Hanson (Filed With SEC on February 14, 2024)
- Form of Subscription Agreement, dated February 13, 2024 (Filed With SEC on February 14, 2024)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on January 29, 2024)
- Amended and Restated Loan and Security Agreement, dated December 22, 2023, by and among enGene Holdings Inc., enGene Inc. and enGene USA, Inc., as borrower, Hercules Capital,... (Filed With SEC on December 28, 2023)
- Form of Closing Date Warrant to Purchase Common Shares of enGene Holdings Inc., pursuant to the Amended and Restated Loan and Security Agreement dated December 22, 2023 (Filed With SEC on December 28, 2023)
- Employment Agreement, dated December 13, 2023, by and between enGene USA, Inc. and Ryan Daws (Filed With SEC on December 13, 2023)
- Employment Agreement, dated November 29, 2023, by and between enGene USA, Inc. and Richard Bryce (Filed With SEC on November 29, 2023)
- Employment Offer Letter, dated November 13, 2023, by and between enGene USA, Inc. and Ryan Daws (Filed With SEC on November 29, 2023)
- EMPLOYMENT AGREEMENT FOR ANTHONY CHEUNG (Filed With SEC on November 9, 2023)
- Employment Agreement, dated November 8, 2023, by and between enGene USA, Inc. and James Sullivan (Filed With SEC on November 9, 2023)
- Employment Agreement, dated November 8, 2023, by and between enGene USA, Inc. and Alex Nichols (Filed With SEC on November 9, 2023)
- Employment Agreement, dated November 8, 2023, by and between enGene USA, Inc. and Jason D. Hanson (Filed With SEC on November 9, 2023)
- Form of Nonqualified Stock Option Grant Agreement under enGene Holdings Inc. 2023 Incentive Equity Plan (Filed With SEC on October 31, 2023)
- Warrant Assignment, Assumption and Amendment Agreement, dated as of October 30, 2023, among FEAC, enGene, New enGene and Continental Stock Transfer & Trust Company (Filed With SEC on October 31, 2023)
- Registration Rights Agreement, dated October 31, 2023, by and among enGene Holdings Inc., Forbion European Acquisition Corp. and each of the Holders identified therein (Filed With SEC on October 31, 2023)
- enGene Holdings Inc. 2023 Incentive Equity Plan (Filed With SEC on October 31, 2023)
- Form of Incentive Stock Option Grant Agreement under enGene Holdings Inc. 2023 Incentive Equity Plan (Filed With SEC on October 31, 2023)
- Form of Restricted Stock Award Agreement under enGene Holdings Inc. 2023 Incentive Equity Plan (Filed With SEC on October 31, 2023)
- Form of Restricted Stock Unit Award Agreement under enGene Holdings Inc. 2023 Incentive Equity Plan (Filed With SEC on October 31, 2023)
- Form of Indemnification Agreement (Filed With SEC on October 31, 2023)
- Loan and Security Agreement, dated December 30, 2021, by and among enGene, enGene USA and Hercules Capital Inc (Filed With SEC on August 9, 2023)
- Lease Agreement, dated December 29, 2022, by and between enGene and Are-Canada No. 5 Holdings, ULC (Filed With SEC on August 9, 2023)
- Lease Amendment Agreement No. 3, dated September 1, 2023, by and between enGene and NeoMed Institute (Filed With SEC on August 9, 2023)
- Lease Amendment Agreement No. 2, dated April 1, 2023, by and between enGene and NeoMed Institute (Filed With SEC on August 9, 2023)
- Lease Amendment Agreement, dated October 1, 2022, by and between enGene and NeoMed Institute (Filed With SEC on August 9, 2023)
- Lease Agreement, dated November 1, 2021, by and between enGene and NeoMed Institute, as amended (Filed With SEC on August 9, 2023)
- Letter Agreement, dated May 16, 2023, by and among enGene, IQ, FEAC and New enGene (Filed With SEC on August 9, 2023)
- Master Service Agreement, dated November 11, 2019, by and between enGene and BioAgilytix Labs, LLC (Filed With SEC on August 9, 2023)
